Publications

2018

Lauper K., Gabay C., et al: Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic DMARDs in patients with rheumatoid arthritis after the use of at least one biologic DMARD: analyses from the pan-European TOCERRA register collaboration. [Ann Rheum Dis. 2018; 0:1-7. doi: 10.1136/annrheumdis-2017-212845, https://www.ncbi.nlm.nih.gov/pubmed/29730637]

Lauper K., Gabay C., et al: Incidence and prevalence of major adverse cardiovascular events in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis. [Arthritis Care Res. 2018, doi: 10.1002/acr.23567, https://www.ncbi.nlm.nih.gov/pubmed/29609199]

Heinimann, K., von Kempis, J., et al.: Long-Term Increase of Radiographic Damage and Disability in Patients with RA in Relation to Disease Duration in the Era of Biologics. Results from the SCQM Cohort. J. Clin. Med. 2018, 7, 57; doi:10.3390/jcm7030057

Hebeisen, M., Ciurea A., et al.: Response to Tumor Necrosis Factor Inhibition in Male and Female Patients with Ankylosing Spondylitis: Data from a Swiss Cohort. [The Journal of Rheumatology 2018, http://www.jrheum.org/content/early/2018/02/08/jrheum.170166]

2017

Zufferey P., Ziswiler HR, A. et al: Can Ultrasound Be Used to Predict Loss of Remission in Patients with RA in a Real-life Setting? A Multicenter Cohort Study. [The Journal of Rheumatology 2018; 45:3; doi:10.3899/jrheum.161193, https://www.ncbi.nlm.nih.gov/pubmed/29335344]

Molnar, C., Scherer, A. et al.: TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort. Ann Rheum Dis. 2017 Sep 22. pii: annrheumdis-2017-211544. doi: 10.1136/annrheumdis-2017-211544. [Epub ahead of print]

Micheroli, R., Hebeisen, M., Ciurea, A. et al.: Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis. Arthritis Res Ther. 2017 Jul 19;19(1):164. doi: 10.1186/s13075-017-1372-3.

Stekhoven, D., Scherer, A., Nissen, M.J. et al.: Hypothesis-free analyses from a large psoriatic arthritis cohort support merger to consolidated peripheral arthritis definition without subtyping. Clin Rheumatol (2017), doi:10.1007/s10067-017-3637-2, 22 April 2017

Chaigne B et Finckh A et al: Differential impact of systemic lupus erythematosus and rheumatoid arthritis on health-related quality of life. Qual Life Res. 2017 Mar 11. doi: 10.1007/s11136-017-1534-4. [Epub ahead of print]

Chatzidionysiou K and Gabay C et al: Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration. J Rheumatol. 2017 Feb;44(2):162-169. doi: 10.3899/jrheum.160460. Epub 2017 Jan 15.

2016

Iannone F and Finckh A et al: Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA). Clin Rheumatol. 2016 Dec 14. PMID: 27966068 DOI: 10.1007/s10067-016-3505-5 [Epub ahead of print]

Mueller RB et al, “Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM)”. Clin Rheumatol. 2016 Nov 12. [Epub ahead of print]

Nissen MJ et al: “The Effect of Comedication With a Conventional Synthetic Disease-Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti-Tumor Necrosis Factor Therapy in Patients With Axial Spondyloarthritis.” Arthritis Rheumatol. 2016 Sep;68(9):2141-50. doi: 10.1002/art.39691.

Courvoisier DS and Finckh A et al. “Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study.” EBioMedicine. 2016 Sep;11:302-306. doi: 10.1016/j.ebiom.2016.08.024.

Gottenberg JE and Finckh A et al., "Brief Report: Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis", Arthritis Rheumatology 2016, 68(6): 1346-52.

Mercer LK and Finckh A et al., "Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 Eurpean biologics registers", Ann Rheum Dis 2016 [Epub ahead of print].

Katerina Chatzidionysiou, Cem Gabay et al, “Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration” Arthritis Res Ther. 2016; 18: 50. Published online 2016 Feb 16.

Adrian Ciurea et al., "Does the reason for discontinuation of a firt TNF inhibitor influence the effectiveness of a second TNF inhibitor in axial spondyloarthritis? Results from the Swiss Clinical Quality Management Cohort", Arthritis Research & Therapy 2016, 18:71.

ACR Washington, DC (11-16 November 2016)

EULAR London (8-11 June 2016)

2015

Axel Finckh et al., "The impact of patient heterogeneity and socio-economic factors across nine European countries on abatacept retention in rheumatoid arthritis". RMD Open. 2015 Apr 30;1(1): PMID: 26509062.

Ulrich Walker et al., Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis, Rheumatology 2015 Aug 27. pii: kev297. [Epub ahead of print]

Cem Gabay et al., Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study, Ann Rheum Dis. 2015 Sep 15. pii: annrheumdis-2015-207760. doi: 10.1136/annrheumdis-2015-207760. [Epub ahead of print]

Cem Gabay et al., Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDsin rheumatoid arthritis: data from the Swiss Clinical Quality Management registry. Rheumatology, 2015 April 27. pii: kev019. [Epub ahead of print]

Adrian Ciurea et al., Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis. Ann Rheum Dis. 2015 Feb 9. pii: annrheumdis-2013-205133. doi: 10.1136/annrheumdis-2013-205133. [Epub ahead of print]

ACR San Francisco, November 6-11, 2015

ESBB - Biobanking Conference London, 29th September to Friday 2nd, 2015

EULAR Rome (10 - 13 June 2015)

2014

Adrian Ciurea et al.,Treatment with Tumor Necrosis Factor Inhibitors in Axial Spondyloarthritis: Comparison Between Private Rheumatology Practices and Academic Centers in a Large Observational Cohort, The journal of Rheumatology, November 1, 2014, doi: 10.3899/jrheum.140229

Adrian Ciurea et al., Age at symptom onset in ankylosing spondylitis: is there a gender difference? Ann Rheum Dis, Published Online First: 7 August 2014

Elena Ciubotariu et al., Joint Damage Progression in Patients with Rheumatoid Arthritis in Clinical Remission. Do Biologics Perform Better Than Synthetic Antirheumatic Drugs? The journal of Rheumatology, Published online before print July 15, 2014, doi: 10.3899/jrheum.130767

Rüdiger Müller et al., The new 2010 ACR/EULAR criteria as predictor of clinical and radiographic response in patients with early arthritis, Clinical Rheumatology, 2014 Jul 15. [Epub ahead of print]

Pascal Zufferey et al., Persistence of ultrasound synovitis in patients with rheumatoid arthritis fulfilling the DAS28 and/or the new ACR/EULAR RA remission definitions: Results of an observational cohort study, Joint Bone Spine, DOI: 10.1016/j.jbspin.2014.04.01

ACR Boston (14 – 19 November 2014)

EULAR Paris (11 - 14 June 2014)

2013

Adrian Ciurea and Axel Finckh, Smoking and Spondyloarthritis, editorial, Joint Bone Spine 2013, 80: 234-5.

Pascal Zufferey et al., Recommendations for the use of ultrasound in rheumatoid arthritis: literature review and SONAR score experience, Swiss Med Wkly. 2013;143:w13861

Burkhard Möller et al., Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study, Ann. Rheum, published on December 19, 2013 as 10.1136/annrheumdis-2013-204078

Rüdiger Müller et al., Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort, Rheumatology (Oxford). 2013 Dec 17. [Epub ahead of print]

Pascal Zufferey et al., Ultrasound evaluation of synovitis in RA: Correlation with clinical disease activity and sensitivity to change in an observational cohort study, Joint Bone Spine, Available online 5 November 2013

Adrian Ciurea et al., Tumor necrosis factor-α inhibition in radiographic and non-radiographic axial spondyloarthritis: results from a large observational cohort, Arthritis and Rheumatism 13-0025.R2; DOI: 10.1002/art.38140

Burkhard Möller et al., "Anaemia may add information to standardized disease activity assessment to predict radiographic damage in rheumatoid arthritis - a prospective cohort study", Ann Rheum Dis 2013 Mar 16. [Epub ahead of print]

ACR Congress, San Diego, 25–30 October 2013

SGR Interlaken (11 - 13 September 2013)

EULAR Madrid (12 - 15 June 2013)

2012

Pascal Zufferey et al., "Disease activity in rheumatoid arthritis patients at initiation of biologic agents and 1 year of treatment: Results from the Swiss SCQM registry", Joint Bone Spine, July 2013 Mar;80(2):160-4. doi: 10.1016/j.jbspin.2012.05.003. Epub 2012 Jul 4.

Axel Finckh et al.,"Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists", Ann Rheum Dis, March 2012

Delphine S Courvoisier et al., "Pain as an important predictor of psychosocial health in patients with rheumatoid arthritis." Arthritis care & research, Feb. 2012; 64(2):190-6

Sophie Martin Du Pan et al., "Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients", 2012 Jun;71(6):997-9. doi: 10.1136/annrheumdis-2011-200882. Epub 2012 Jan 30.

ACR/ARHP Annual Meeting Washington (9-14 November 2012)

Bechterew Symposium (3 November 2012)

SGR Geneva (19 - 21 September 2012)

EULAR Berlin (6 - 9 June 2012)

2011

Katerina Chatzidionysiou et al., "Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration", Ann Rheum Dis 2011 Oct 4.

Katerina Chatzidionysiou et al., "Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries.", Ann Rheum Dis. 2011 Sep;70(9):1575-80

Diego Kyburz et al., "The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study". Rheumatology (Oxford) 2011, Jun;50(6):1106-10. doi: 10.1093/rheumatology/keq424. Epub 2011 Jan 21.

Ulrich Walker et al., "Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion". 2011 Jan;50(1):243-4. doi: 10.1093/rheumatology/keq258. Epub 2010 Aug 17.

ACR Chicago

2010

Axel Finckh at al., "Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients.". 2010 Jul;77(4):313-8. doi: 10.1016/j.jbspin.2010.02.021. Epub 2010 May 14.

Michael Nissen et al., "The effect of alcohol on radiographic progression in rheumatoid arthritis", 2010 May;62(5):1265-72. doi: 10.1002/art.27388.

Curtis JR et al., "A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries". Semin Arthritis Rheum. 2010 Aug;40(1):2-14.e1.

ACR Atlanta

2009

Du Pan SM, Dehler S, Ciurea A, Ziswiler HR, Gabay C, Finckh A, "Comparison of drug retension rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis". Ann Rheum Dis. 2009 May 15; 61(5): 560-9.

Finckh A, Dehler S, Gabay C; SCQM doctors. "The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study." Ann Rheum Dis. 2009 Jan;68(1):33-9.

Axel Finckh et al., "Which subgroup of rheumatoid arthritis patients benefits from switching to rituximab versus alternative anti-TNF agents after previous failure to anti-TNF agent?". 2010 Feb;69(2):387-93. doi: 10.1136/ard.2008.105064. Epub 2009 May 4.

2007

Finckh A , Dehler S, Costenbader K, Gabay C, on behalf of the SCQM-RA, "Cigarette smoking and radiographic progression in rheumatoid arthritis". Annals of the Rheumatic Diseases 2007; 66; 1066-1071.

Finckh A, Ciurea A, Brulhart L, Revaz S, Möller B, Dehler S, Kyburz D, Dudler J, Gabay C, on behalf of the SCQM-RA, "B-cell depletion may be more effective than switching to an alternative anti-TNF agent in RA patients with inadequate response to anti-TNF agents". Arthritis and Rheumatism 2007; May 2007; 56(5), 1417-23.

Genevay S, Finckh A, Ciurea A, Chamot AM, Kyburz D, Gabay C, for the physician of the SCQM-RA (* Authors have equally contributed), "Tolerance and effectiveness of anti-TNF-a therapies in elderly patients with rheumatoid arthritis. A population based cohort study". Arthritis and Rheumatism (AC&R) 2007 Apr 30; 57(4):679-685.

2006

Finckh A, Simard J, Gabay C, Guerne PA, for the physician of the SCQM-RA, "Evidence for differential acquired drug resistance to anti-TNF agents in rheumatoid arthritis". Annals of Rheumatic Diseases 2006 Jun; 65(6):746-52.

Finckh A, Simard JF, Huang J, Duryea J, Liang M, Daneel S, Forster A, Gabay C, Guerne PA., "The effectiveness of anti-TNF therapy in preventing progressive radiographic joint damage in rheumatoid arthritis. A population based study". Arthritis and Rheumatism, 2006 Jan; 54(1):54-9. Pfizer Price 2006 for medical research: Clinical rheumatology and immunology.

Genta MS, Kardes H, Gabay C., "Clinical evaluation of a cohort of patients with rheumatoid arthritis treated with anti-TNF-alpha in the community". Joint Bone Spine, 2006 Jan; 73(1):51-6.

2000

E. Uitz, J. Fransen , T. Langenegger and G. Stucki for the members of the SCQM-RA, "Clinical quality management in rheumatoid arthritis: putting theory into practice". Rheumatology 2000; 39:542-549.